Company Profile

IFCI LTD.

NSE : IFCIBSE : 500106ISIN CODE : INE039A01010Industry : Finance Term LendingHouse : PSU
BSE4.120.01 (+0.24 % )
PREV CLOSE (Rs.) 4.11
OPEN PRICE (Rs.) 4.23
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 260352
TODAY'S LOW / HIGH (Rs.)4.10 4.23
52 WK LOW / HIGH (Rs.)3.1 13.55
NSE4.15 0.05 (+1.22 % )
PREV CLOSE(Rs.) 4.10
OPEN PRICE (Rs.) 4.20
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 4.15 (33886 )
VOLUME 1112723
TODAY'S LOW / HIGH(Rs.) 4.10 4.20
52 WK LOW / HIGH (Rs.)3.1 13.55

Company News

Date Heading Details
05-Feb-2020 Reliance Industries, Apollo Micro Systems and Cadila Healthcare to see some action today <p align="justify"><strong>Reliance Industries</strong> has acquired additional 65,956 equity shares, representing 10.9% of the equity share capital, of Saavn Media (Saavn India) from the existing shareholders for a total consideration of Rs 653.93 crore on February 3, 2020. After acquisition, the company will hold 94.4% of the equity share capital of Saavn India.<p align="justify"><strong>Apollo Micro Systems</strong> has duly signed the Investment cum Shareholders Agreement with Ananya SIP RF Technologies (ASIP RF) in order to acquire majority stake in ASIP RF ie. 51 % equity share capital. The acquisition aims to expand the business towards new technologies by establishing a RF &amp; Microwave Design cum production facility along with integration facility. <p align="justify">The USFDA has inspected the manufacturing facility of Alidac Pharmaceuticals, <strong>Cadila Healthcare's</strong> wholly-owned subsidiary, located at SEZ, Ahmedabad from January 27 to February 4, 2020. At the end of the inspection, no observation (483) is issued. The site manufactures oncology injectables for the regulated markets.<p align="justify"><strong>Sun Pharmaceutical Industries</strong> has launched ABSORICA LD (isotretinoin) capsules in U.S. for the management of severe recalcitrant nodular acne in patients 12 years of age and older. ABSORICA LD is the only isotretinoin formulation to feature Sun Pharma's micronization technology, which utilizes micronized particles to optimize absorption at a 20% lower dose. ABSORICA LD can be taken with or without food. <p align="justify"><strong>Balmer Lawrie &amp; Company</strong> has received approval to exit from start-up- ‘Kanpur Flowercycling' by sale of 479 equity shares held by the Company to IAN Fund and IAN individuals at a total consideration of Rs 95.14 lakh. The Board of Directors of the Company at its meeting held on February 04, 2020 has approved the same.<p align="justify"><strong>Lumax Industries</strong> has redeemed commercial paper of Rs 50 crore on February 3, 2020. The said commercial paper was issued on November 7, 2019. <p align="justify"><strong>IFCI</strong> has completed the stake sale of National Stock Exchange of India (NSE) and further received an amount of approximately Rs 178.65 crore.</p>
04-Feb-2020 IFCI divests stake in NSE <p align="justify">IFCI has completed the stake sale of National Stock Exchange of India (NSE) and further received an amount of approximately Rs 178.65 crore.<p align="justify">Earlier, the company has received bids for sale of 1,20,66,871 equity shares comprising of 2.44% of the total equity shares in NSE. <p align="justify">IFCI was established with intent to provide long-term finance needs of the industrial sector. It founded and developed various institutions namely ICRA for credit assessment rating, Tourism Finance Corporation of India (TFCI) for promotion of the hospitality industry, among others.</p>
31-Jan-2020 IFCI informs about board meeting <p align="justify">IFCI has informed that pursuant to the provision of Regulations 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, February 13, 2020, to consider and approve the Standalone and Consolidated Financial Results of the Company for the quarter ended December 31, 2019. In view of the above, and in continuation to Letter No: IFCl/CS/2019-1050 dated December 30, 2019; the trading window shall remain closed till Saturday, February 15, 2020, for the aforesaid purpose.<p align="justify">The above information is a part of company's filings submitted to BSE.</p>
28-Jan-2020 IFCI informs about payment of interest <P align=justify>IFCI has confirmed that payment of interest was due on January 25, 2020 for 9.75% Fully Unsecured Non-Convertible Regular Return Bonds in the form of Promissory Notes - Series - 47 (ISIN - INE039A09LC6). However, as January 25-26, 2020 being holidays, hence as per the Information Memorandum, the payment was made on January 27, 2020.&nbsp;<P align=justify>The above information is a part of company's filings submitted to BSE.
09-Jan-2020 IFCI informs about issue of duplicate share certificate <p align="justify">Pursuant to the provisions of Regulation 39 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, IFCI has informed that it has enclosed herewith the request received for issue of duplicate share certificates. <br></p><p align="justify">The above information is a part of company's filings submitted to BSE.</p>
26-Dec-2019 IFCI realizes Rs 805.60 crore from NSE stake sale <p align="justify">IFCI has realized an amount of approximately Rs 805.60 crore from the divestment of its remaining 2.44%&nbsp; stake in National Stock Exchange (NSE), representing about 82% of the total committed amount. Process for receipt of approval for remaining quantity is underway.<br></p><p align="justify">IFCI was established with intent to provide long-term finance needs of the industrial sector. It founded and developed various institutions namely ICRA for credit assessment rating, Tourism Finance Corporation of India (TFCI) for promotion of the hospitality industry, among others.<br></p>
24-Dec-2019 IFCI informs about disinvestment <p align="justify">In continuation to Letter No. IFCI/CS/2019-1016 dated December 02, 2019 regarding disinvestment of the company's entire stake in Exchange comprising of 1,20,66,871 number of equity shares comprising of 2.44% of the total equity shares of Exchange, IFCI has informed that the company has realized an amount of approximately 805.60 crore, representing about 82% of the total committed amount. Process for receipt of approval for remaining quantity is underway.&nbsp;<p align="justify">The above information is a part of company's filings submitted to BSE.</p>
03-Dec-2019 IFCI receives bids for sale of its entire stake in NSE <p align="justify">IFCI has received bids for sale of 1,20,66,871 equity shares comprising of 2.44% of the total equity shares in National Stock Exchange of India (NSE). The sale will be subject to obtaining consent/ No objection of NSE and any other approval. Earlier, the company had received Board of Directors' approval to sell its remaining stake of NSE.<br></p><p align="justify">IFCI was established with intent to provide long-term finance needs of the industrial sector. It founded and developed various institutions namely ICRA for credit assessment rating, Tourism Finance Corporation of India (TFCI) for promotion of the hospitality industry, among others.<br></p><p align="justify"><br></p>
03-Dec-2019 IFCI shines on receiving bids for sale of its entire stake in NSE <p align="justify">IFCI is currently trading at Rs. 7.37, up by 0.39 points or 5.59% from its previous closing of Rs. 6.98 on the BSE.<br></p><p align="justify">The scrip opened at Rs. 7.49 and has touched a high and low of Rs. 7.65 and Rs. 7.21 respectively. So far 405023 shares were traded on the counter.<br></p><p align="justify">The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 15.35 on 01-Jan-2019 and a 52 week low of Rs. 6.00 on 15-Oct-2019.<br></p><p align="justify">Last one week high and low of the scrip stood at Rs. 7.65 and Rs. 6.85 respectively. The current market cap of the company is Rs. 1251.64 crore.<br></p><p align="justify">The promoters holding in the company stood at 56.42%, while Institutions and Non-Institutions held 16.76% and 26.82% respectively.<br></p><p align="justify">IFCI has received bids for sale of 1,20,66,871 equity shares comprising of 2.44% of the total equity shares in National Stock Exchange of India (NSE). The sale will be subject to obtaining consent/ No objection of NSE and any other approval. Earlier, the company had received Board of Directors' approval to sell its remaining stake of NSE.<br></p><p align="justify">IFCI was established with intent to provide long-term finance needs of the industrial sector. It founded and developed various institutions namely ICRA for credit assessment rating, Tourism Finance Corporation of India (TFCI) for promotion of the hospitality industry, among others.<br></p>
29-Nov-2019 IFCI informs about related party transaction <p align="justify">IFCI has informed that pursuant to the provisions of Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the statement of related party transactions on consolidated basis for the half-year ended September 30, 2019 is enclosed.<p align="justify">The above information is a part of company's filings submitted to BSE.</p>